-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Misses Q1 EPS by 21c ; Offers Guidance
-
-
-
-
-
-
-
Harmony Biosciences forecasts WAKIX revenue to exceed $1 billion in 2026
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q2 EPS by 20c ; Offers Guidance
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q3 EPS by 12c, provides guidance
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q1 EPS by 25c
-
-
-
-
-
-
-
HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE
-
1,234,518 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


